Birchview Capital

Latest statistics and disclosures from Birchview Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Birchview Capital

Companies in the Birchview Capital portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bristol Myers Squibb (BMY) 39.6 $55M -5% 754k 73.03
Neurocrine Biosciences (NBIX) 6.0 $8.4M +11% 89k 93.75
Aziyo Biologics (AZYO) 6.0 $8.3M +2735% 1.4M 5.84
Quidel Corporation (QDEL) 4.8 $6.7M 60k 112.46
ACADIA Pharmaceuticals (ACAD) 3.5 $4.8M 199k 24.22
Foghorn Therapeutics (FHTX) 3.2 $4.5M -6% 294k 15.23
Albireo Pharma (ALBO) 2.4 $3.4M 113k 29.83
Accelr8 Technology (AXDX) 2.3 $3.2M 2.3M 1.44
United Therapeutics Corporation (UTHR) 2.3 $3.2M 18k 179.39
Continental Resources (CLR) 1.7 $2.4M 39k 61.32
Biogen Idec (BIIB) 1.5 $2.1M -19% 10k 210.59
Biodesix (BDSX) 1.5 $2.1M +13% 1.3M 1.69
Karyopharm Therapeutics (KPTI) 1.4 $2.0M +9% 269k 7.37
Encana Corporation (OVV) 1.3 $1.8M 34k 54.06

Setup an alert

Birchview Capital will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Biohaven Pharmaceutical Holding (BHVN) 1.2 $1.7M +40% 14k 118.57
Prothena Corp SHS (PRTA) 1.1 $1.5M +4% 42k 36.57
Masimo Corporation (MASI) 1.0 $1.4M +16% 9.3k 145.58
Alkermes SHS (ALKS) 0.9 $1.3M 50k 26.32
Harrow Health (HROW) 0.9 $1.2M 180k 6.82
Corcept Therapeutics Incorporated (CORT) 0.8 $1.1M 50k 22.52
Inhibrx (INBX) 0.8 $1.1M NEW 50k 22.28
Equitrans Midstream Corp (ETRN) 0.8 $1.1M 133k 8.44
Gossamer Bio (GOSS) 0.8 $1.1M +222% 129k 8.68
Docgo (DCGO) 0.7 $1.0M NEW 110k 9.25
Arvinas Ord (ARVN) 0.7 $1.0M 15k 67.33
Amarin Corp Spons Adr New (AMRN) 0.7 $987k 300k 3.29
Pioneer Natural Resources (PXD) 0.7 $950k 3.8k 250.00
Cytokinetics (CYTK) 0.7 $920k 25k 36.80
ImmunoGen (IMGN) 0.7 $904k 190k 4.76
Protagonist Therapeutics (PTGX) 0.6 $900k 38k 23.68
Soleno Therapeutics 0.6 $820k +319% 3.7M 0.22
Aveo Pharmaceuticals (AVEO) 0.6 $783k +250% 140k 5.59
Contrafect 0.5 $730k 200k 3.65
Inari Medical Ord (NARI) 0.5 $725k +14% 8.0k 90.62
Nektar Therapeutics (NKTR) 0.5 $690k +77% 128k 5.39
Irhythm Technologies (IRTC) 0.5 $630k 4.0k 157.50
Apellis Pharmaceuticals (APLS) 0.4 $610k 12k 50.83
Kalvista Pharmaceuticals (KALV) 0.4 $590k 40k 14.75
2seventy Bio (TSVT) 0.4 $586k NEW 34k 17.07
Vanda Pharmaceuticals (VNDA) 0.4 $566k -37% 50k 11.32
Chemocentryx (CCXI) 0.4 $501k -20% 20k 25.05
Cullinan Oncology (CGEM) 0.3 $472k 45k 10.46
Silk Road Medical Inc Common (SILK) 0.3 $413k NEW 10k 41.30
Bluebird Bio (BLUE) 0.3 $407k 84k 4.85
Zentalis Pharmaceuticals (ZNTL) 0.3 $369k 8.0k 46.12
Amicus Therapeutics (FOLD) 0.3 $360k 38k 9.47
Ventyx Biosciences (VTYX) 0.2 $339k NEW 25k 13.56
Xencor (XNCR) 0.2 $328k 12k 26.67
BioCryst Pharmaceuticals (BCRX) 0.2 $325k 20k 16.25
Stoke Therapeutics (STOK) 0.2 $316k 15k 21.07
G1 Therapeutics (GTHX) 0.2 $304k 40k 7.60
Kiniksa Pharmaceuticals (KNSA) 0.2 $298k 30k 9.93
Phreesia (PHR) 0.2 $264k NEW 10k 26.40
Iveric Bio (ISEE) 0.2 $252k 15k 16.80
Turning Point Therapeutics I (TPTX) 0.2 $215k 8.0k 26.88
Inflarx Nv (IFRX) 0.1 $128k 70k 1.83
Angion Biomedica Corp (ANGN) 0.1 $115k 54k 2.11
Aspira Womens Health (AWH) 0.1 $107k 103k 1.04
Laird Superfood (LSF) 0.1 $101k +100% 28k 3.61
Yield10 Bioscience 0.1 $99k 19k 5.28
Sientra (SIEN) 0.1 $89k 40k 2.23
Concert Pharmaceuticals I equity (CNCE) 0.0 $67k 20k 3.35
Akebia Therapeutics (AKBA) 0.0 $14k -80% 20k 0.70

Past Filings by Birchview Capital

SEC 13F filings are viewable for Birchview Capital going back to 2014

View all past filings